Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (XT) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sales |
8.73 |
44.80 |
10.29 |
14.54 |
5.95 |
Operating profit |
1.47 |
5.42 |
1.43 |
4.62 |
-1.73 |
Interest |
0.17 |
0.15 |
0.16 |
0.25 |
0.04 |
Gross profit |
3.03 |
6.15 |
1.30 |
1.82 |
0.86 |
EPS (Rs) |
0.23 |
4.68 |
2.58 |
4.44 |
0.36 |
Half yearly
results in details
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Other income |
1.74 |
0.88 |
0.04 |
-2.55 |
2.63 |
Stock adjustment |
-0.84 |
1.79 |
-0.55 |
0.05 |
-0.79 |
Raw material |
2.37 |
6.82 |
6.06 |
6.87 |
4.21 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
2.81 |
2.72 |
2.50 |
2.73 |
2.17 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
2.92 |
28.05 |
0.85 |
0.26 |
2.09 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
1.36 |
1.02 |
0.87 |
0.93 |
0.74 |
Taxation |
0.65 |
- |
0.03 |
0.20 |
0.07 |
Net profit / loss |
1.02 |
5.13 |
0.40 |
0.69 |
0.06 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
43.79 |
10.96 |
1.57 |
1.57 |
1.57 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
16.86 |
12.11 |
13.87 |
31.75 |
-29.11 |
GPM (%) |
28.99 |
13.47 |
12.64 |
15.19 |
10.01 |
NPM (%) |
9.78 |
11.23 |
3.92 |
5.79 |
0.66 |